Loading the player...
Closed Captioning / Subtitles Available
Information
Irritable Bowel Syndrome in Women
Copyright :
Irritable bowel syndrome (IBS) affects 12% of the population, with females twice as likely to suffer from this illness. Many patients with IBS are difficult to treat, for many reasons that Dr. Peter Buch, a clinical gastroenterologist, will explore. This case-based presentation will provide the answers to challenging and common questions:
- How do you best diagnose IBS with the testing that is available today?
- Who should be referred to a gastroenterologist for care?
- Should all patients get a colonoscopy?
- What are the current evidence-based treatments?
Peter Buch, MD, AGAF, FACP
Peter Buch, MD, AGAF, FACP, is a double board-certified clinical gastroenterologist, leading a team that treats all GI conditions. Dr. Buch sits on editorial boards for numerous professional journals and is a highly sought-after international presenter.
Dr. Buch has a passion for teaching. His style is case-based, practical, very interactive and evidence supported. Dr. Buch’s expertise has been shared with experienced clinicians and advanced-level students. He teaches at the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, the Frank H Netter School of Medicine/Quinnipiac University and the University of Connecticut APRN School.
Speaker Disclosures:
Financial: Dr. Peter S. Buch has employment relationships with the University of Connecticut School of Medicine, the University of New England College of Osteopathic Medicine, and the Frank H Netter, MD School of Medicine. He receives a speaking honorarium and recording royalties from 小蝌蚪视频. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Peter S. Buch serves on the FDA and Patient Care Committees at the American College of Gastroenterology. He serves as an editor of peer-reviewed journals. He is a member of the International Association of Medical Science Educators, the AGA Academy of Educators, the American Gastroenterological Association (AGAF), the American College of Physicians (FACP), the Hartford County Medical Association, the American College of Gastroenterology (FACG), and the Connecticut State Medical Society.
Content Disclosure:
Dr. Buch references the use of antidepressants for Irritable Bowel Syndrome, and the controversial use of Fibrotest to evaluate patients with fatty liver disease who may have fibrosis of the liver. Dr. Buch indicates he wishes to present a fair and balanced approach to practitioners regarding such practices.